Prazosin SR Tablet Prazobrook XL 5
Description
Prazobrook XL 5mg Prazosin Sustained-Release Tablets
Understanding the Sustained-Release Formulation:
A sustained-release tablet releases medicine gradually over an extended period. This differs from a conventional immediate-release capsule or tablet.
Because the release mechanism depends on the tablet remaining intact:
- Swallow it whole with sufficient water.
-Do not crush, chew, or split it.
-Do not substitute it with an immediate-release prazosin product without medical approval.
- Follow the administration schedule stated on the prescription.
Product Identification
Brand name: Prazobrook XL 5
Active content name: Prazosin
Composition: Prazosin Hydrochloride sustained-release tablet
Expected strength: Equivalent to Prazosin 5 mg
Dosage form: Sustained-release oral tablet
Medicine category: Alpha-1 adrenergic blocker
Therapeutic category: Antihypertensive medicine
Route of administration: Oral
Where Prazosin May Be Used:
1. Management of High Blood Pressure
Prazosin blocks alpha-1 receptors located in blood vessels. This helps the vessels relax and widen, allowing blood to flow more easily and lowering vascular resistance. Controlling high blood pressure is important because persistent hypertension can increase stress on the heart, kidneys, blood vessels, and other organs.
2. Benign Prostatic Hyperplasia:
In some markets, sustained-release prazosin is also indicated for benign prostatic hyperplasia. By relaxing smooth muscle around the prostate and bladder outlet, it may improve certain urinary symptoms in eligible patients.
What Are the Potential Benefits?
Under appropriate medical supervision, Prazobrook XL 5 may:
-Support the management of high blood pressure
-Reduce resistance within the blood vessels
- Improve blood flow by relaxing vascular smooth muscle.
-Form part of a combined antihypertensive treatment plan
- Help selected patients with urinary symptoms related to an enlarged prostate
- Provide gradual release of prazosin over an extended period
Frequently Asked Questions
1. What is Prazobrook XL 5?
Prazobrook XL 5 is a prescription sustained-release tablet containing prazosin hydrochloride, expected to be equivalent to Prazosin 5 mg.
2. Which medicine category does it belong to?
It belongs to the alpha-1 adrenergic blocker category and is classified therapeutically as an antihypertensive medicine.
3. What is Prazobrook XL 5 used for?
It may be prescribed for high blood pressure. Depending on the locally approved indication, it may also be used for urinary symptoms associated with benign prostatic hyperplasia.
4. How does prazosin reduce blood pressure?
Prazosin blocks alpha-1 receptors and relaxes blood vessels. This reduces vascular resistance and allows blood to flow more easily.
5. Can the sustained-release tablet be crushed?
No. Crushing, chewing, or dividing the tablet can interfere with its controlled-release mechanism. It should be swallowed whole unless the approved label specifically states otherwise.
6. Is Prazobrook XL 5 suitable as the first prazosin dose?
The 5mg strength is generally not used to begin prazosin treatment. A doctor usually selects a lower starting dose and increases it gradually to reduce the risk of severe dizziness or fainting.
7. What are the common side effects?
Possible side effects include dizziness, headache, drowsiness, weakness, nausea, palpitations, and light-headedness when standing.
8. Can it be taken with erectile dysfunction medicines?
Prazosin and PDE-5 inhibitors can both lower blood pressure. They should be combined only after a healthcare professional assesses the patient and provides suitable instructions.
9. What should a patient do after missing a dose?
The patient should follow the missed-dose instructions provided by the doctor or the approved product leaflet. Two doses should not be taken together unless specifically directed by a healthcare professional.
10. What is Prazobrook XL 5 used for?
Prazobrook XL 5 contains prazosin in a sustained-release formulation. A doctor may prescribe it to manage high blood pressure and, where locally approved, urinary symptoms associated with benign prostatic hyperplasia. It should be taken only under medical supervision.
